Case File
efta-01759658DOJ Data Set 10OtherEFTA01759658
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01759658
Pages
3
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Thomas Turrin
Sent:
Tuesday, Augus
To:
Jeffrey Epstein
Cc:
Eileen Alexanderson
Subject:
FW: AVIONETA - RANCE
Jeffrey,
Michael Mandel's=update is below...
From: Mandel, =ichael
Sent: Tuesday, August 27, 2013 3:09 PM
To: Thomas Turrin; Fenn, Patrick
Cc: Eileen Alexanderson; Daigle, Brian
Subject: RE: AVIONETA - RANCE
=nbsp;
Torn, Jet Aviation has =egun the Part 135 certification process. They have advised us that, =ecause of delays with the
FAA, they do not anticipate that the aircraft will be Part 135 certificated until sometime in October.
We are in the process =f finalizing an amended and restated Part 91 management agreement between =et Aviation and
Leon individually (Leon is really the proper party for such agreement) and a Part 135 dry lease agreement between Jet
a=d Rance (the legal title holder). As you know, the plan is to have a=l flights be 135 if possible. We have submitted the
drafts to Bank o= America to obtain lender consent.
Let me know if you nee= anything further.
Michael S. Mandel
EFTA_R1_00063547
EFTA01759658
From: Thomas T=rrin
Sent: Tuesday, August 27, 2013 3:01 PM
To: Mandel, Michael; Fenn, Patrick
Cc: Eileen Alexanderson
Subject: AVIONETA - RANCE
Michael,
Jeffrey Epstein asked me to follow up on the plane r=structuring.
Please let me know how it's progressing.<=o:p>
THANK YOU,
TOM
THOMAS TURRIN, CPA<=p>
Partner
Raich Ende Matter & =o. LLP
1375 Broadway<=o:p>
New York, New York =0018
Website: www.rem-co.com
2
EFTA_R1_00063548
EFTA01759659
&n=sp;
&=bsp;
CONFIDENTIALITY STATEMENT=/strong>: The information c=ntained in this electronic communication, including any and
all attachments and en=losures, may be privileged and is strictly confidential, intended solely f=r the use of the person(s)
identified above to receive this communication.=lf you are not the person(s) identified above to receive this
communication, you are hereby notified that you may =ot disclose print, copy, disseminate, or otherwise use the
information con=ained herein. If you are an employee or agent of the person(s) identified =bove to receive this
communication and, as such, you have been authorized to deliver this communication to su=h person(s), you may
disclose, print, copy, disseminate, or otherwise use =he information contained in this communication solely for the
purpose of s=ch delivery. Unauthorized interception and/or use of this communication are/is strictly prohibited and may
be pun=shable by law. If you have received this communication in error, please re=ly and notify the sender (only) of that
fact and delete the communication,=including any and all attachments and enclosures, from your computer or other
electronic device on which you=may have received this communication.
CIRCULAR 230 DISCLOSURE:<=strong> To insure compliance with requirements impos=d by the Internal Revenue
Service, we inform you that any tax advice contained =n this communication (including any and all attachments), unless
expressly=stated otherwise, was not intended or written to be used and cannot be use= for the purpose of (i) avoiding
tax-related penalties imposed by the Internal Revenue Code or (ii) promoti=g, marketing, or recommending to another
party any transaction(s) or tax-r=lated matter(s) addressed herein. This communication may not be forwarded =other
than to the addressee(s) identified above) without our express written consent.</=>
IRS Circular 230 Notice Requirement: This communication is not given in the=form of a covered opinion, within the
meaning of Circular 230 issued by th= United States Secretary of the Treasury. Thus, we are required to inform =ou that
you cannot rely upon any tax advice contained in this communication for the purpose of avoiding Uni=ed States federal
tax penalties. In addition, any tax advice contained in =his communication may not be used to promote, market or
recommend a transa=tion to another party.
The information contained in this e-mail message is intended only for the p=rsonal and confidential use of the
recipient(s) named above. If you have r=ceived this communication in error, please notify us immediately by e-mail= and
delete the original message.
3
EFTA_R1_00063549
EFTA01759660
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
www.rem-co.comRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.